First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

Stopped Study was terminated due to unacceptable treatment-related toxicity that raised safety concerns and outweighed the potential benefits.

Conditions

• Intrahepatic Cholangiocarcinoma

Interventions

• RADIATION: Radiotherapy
• DRUG: HAIC (GEMOX)
• DRUG: Chemotherapy

Sponsor

Shandong Cancer Hospital and Institute